| 1 | Benralizumab | Benralizumab | 1件: D09874D09874 💬 | IL5RA1件: IL5RA 💬 | Cytokine-cytokine receptor interaction4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer | 0444件: 44, 45, 98, 162 💬 | 
| 2 | Biological: benralizumab, biological: placebo to mepolizumab | Benralizumab | 2件: D04923D04923, D09874D09874 💬 | IL52件: IL5, IL5RA 💬 | Allograft rejection13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation | 0441件: 44 💬 | 
| 3 | Biological: mepolizumab, biological: placebo to benralizumab | Benralizumab | 2件: D04923D04923, D09874D09874 💬 | IL52件: IL5, IL5RA 💬 | Allograft rejection13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation | 0441件: 44 💬 |